Article
Development of a chemically modified recombinant α1-antitrypsin mutant expressed in E. coli for therapeutic applications.
International journal of biological macromolecules - 1 Jan 2026
Yang Dongying, Wang Bo, Wang Xiaoran, Zhu Wei, Lan Tianyi, Lin Mu, Wang Yijie, Wei Xinyao, Li Lanfen, Lin Xinli
Abstract excerpt
Alpha-1-antitrypsin (AAT) is an antiprotease that fulfills a critical physiological function in protecting the lungs from inflammation-induced damage. Inherited AAT deficiency (AATD) represents a clinically significant but often undiagnosed genetic disorder. Native AAT derived from human serum has been utilized as an effective therapeutic agent for treating hereditary emphysema due to AAT deficiency. However, its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
